MENU
+Compare
PRAX
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$52.00
Change
+$2.75 (+5.58%)
Capitalization
1.04B

PRAX Praxis Precision Medicines Forecast, Technical & Fundamental Analysis

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more

PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRAX with price predictions
Sep 25, 2025

Momentum Indicator for PRAX turns positive, indicating new upward trend

PRAX saw its Momentum Indicator move above the 0 level on September 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PRAX's RSI Indicator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRAX just turned positive on September 18, 2025. Looking at past instances where PRAX's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

PRAX moved above its 50-day moving average on September 23, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRAX advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

PRAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRAX entered a downward trend on September 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.565) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (129.870) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PRAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRAX is expected to report earnings to rise 2.42% to -339 cents per share on November 05

Praxis Precision Medicines PRAX Stock Earnings Reports
Q3'25
Est.
$-3.39
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.42
Q4'24
Missed
by $0.15
Q3'24
Missed
by $0.76
The last earnings report on August 04 showed earnings per share of -330 cents, missing the estimate of -325 cents. With 233.00K shares outstanding, the current market capitalization sits at 1.04B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
99 High Street
Phone
+1 617 300-8460
Employees
82
Web
https://www.praxismedicines.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FNPSX37.69N/A
N/A
ProFunds Financials UltraSector Svc
RYOCX95.23N/A
N/A
Rydex NASDAQ-100® Inv
WBALX16.92N/A
N/A
Weitz Conservative Allocation-Inv Cl
NBGNX62.69N/A
N/A
Neuberger Berman Genesis Inv
WPASX54.44N/A
N/A
AB Concentrated Growth A

PRAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with CDXS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then CDXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+0.57%
CDXS - PRAX
49%
Loosely correlated
-3.23%
MNMD - PRAX
42%
Loosely correlated
-0.51%
DNLI - PRAX
42%
Loosely correlated
-0.37%
OCUL - PRAX
42%
Loosely correlated
-2.55%
ABCL - PRAX
39%
Loosely correlated
-2.52%
More